Telluride Pharmaceutical Corporation

TPC develops ethnobiologically based pharmaceuticals to treat cachexia in AIDS and Cancer patients, and patients with Alzheimer's Disease or decreased memory response.
Tissue and organ transplantation, fertility enhancement, environmental based heavy metal poisoning, in addition to immunodeficient, neuropharmacologic, cardiovascular, and metabolic based diseases, are additional areas of focus.
Brandnames include: CACHEXON, ANOSTE', MEMEX, MEMEX-P, and SEMOV.

Activity:

- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- AIDS
- Alzheimer's Disease
- Cancer
- Cardiovascular
- Neurology
- Reproductive Health
- Transplant

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: